Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy

References

• Xie L, Wang B, Jiang C, et al. BMI is associated with the development of chronic kidney diseases in hypertensive patients with normal renal function. J Hypertens. 2018;36(10):2085–2091. doi:10.1097/HJH.0000000000001817
   Web of Science ®Google Scholar
• Wu C, Wang AY, Li G, Wang L. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy. BMC Nephrol. 2018;19(1). doi:10.1186/s12882-018-1164-2
   Web of Science ®Google Scholar
• Cai H, Zhan Y, Lu J, et al. Body mass index combined with waist circumference can predict moderate chronic kidney disease: a retrospective study. Medicine. 2021;100(12):e25017. doi:10.1097/MD.0000000000025017
   Web of Science ®Google Scholar
• Hong YA, Min JW, Ha MA, et al. The impact of obesity on the severity of clinicopathologic parameters in patients with IgA nephropathy. J Clin Med. 2020;9(9):2824. doi:10.3390/jcm9092824
   Web of Science ®Google Scholar
• Kataoka H, Ono K, Mochizuki T, et al. A body mass index-based cross-classification approach for the assessment of prognostic factors in chronic kidney disease progression. Kidney Blood Press Res. 2019;44(3):362–383. doi:10.1159/000501021
   Web of Science ®Google Scholar
• Juszczak F, Vlassembrouck M, Botton O, et al. Delayed exercise training improves obesity-induced chronic kidney disease by activating AMPK pathway in high-fat diet-fed mice. Int J Mol Sci. 2020;22(1):350. doi:10.3390/ijms22010350
   Web of Science ®Google Scholar
• Wei C, Li T, Xuan X, Hu H, Xiao X, Li J. Serum albumin predicts hyperuricemia in patients with idiopathic membranous nephropathy. Clin Nephrol. 2021;96(4):191–198. doi:10.5414/CN110524
   Web of Science ®Google Scholar
• Zhang XD, Cui Z, Zhang MF, et al. Clinical implications of pathological features of primary membranous nephropathy. BMC Nephrol. 2018;19(1):215. doi:10.1186/s12882-018-1011-5
   PubMed Web of Science ®Google Scholar
• Wei C, He Y, Li T, et al. Glomerulosclerosis predicts poor renal outcome in patients with idiopathic membranous nephropathy. Int Urol Nephrol. 2021;53(3):505–514. doi:10.1007/s11255-020-02641-5
   PubMed Web of Science ®Google Scholar
• Nagaraju SP, Rangaswamy D, Mareddy AS, et al. Impact of body mass index on progression of primary immunoglobulin a nephropathy. Saudi J Kidney Dis Transplant. 2018;29(2):318–325. doi:10.4103/1319-2442.229261
   Web of Science ®Google Scholar
• Ouyang Y, Xie J, Yang M, et al. Underweight is an independent risk factor for renal function deterioration in patients with IgA nephropathy. PLoS One. 2016;11(9):e0162044. doi:10.1371/journal.pone.0162044
   Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. DOI:10.1016/S0140-6736(03)15268-3
   PubMed Web of Science ®Google Scholar
• Chinese Society of Endocrinology. Multidisciplinary clinical consensus on diagnosis and treatment of obesity (2021 edition). Chin J Endocrinol Metab. 2021;37(11):959–972. DOI:10.3760/cma.j.cn311282-20210807-00503
   Google Scholar
• Wu D, Yu Z, Zhao S, Qu Z, Sun W, Jiang Y. Lipid metabolism participates in human membranous nephropathy identified by whole-genome gene expression profiling. Clin Sci. 2019;133(11):1255–1269. doi:10.1042/CS20181110
   Web of Science ®Google Scholar
• Choi WJ, Hong YA, Min JW, et al. Hypertriglyceridemia is associated with more severe histological glomerulosclerosis in IgA nephropathy. J Clin Med. 2021;10(18):4236. doi:10.3390/jcm10184236
   Web of Science ®Google Scholar
• Stangou MJ, Marinaki S, Papachristou E, et al. Histological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patients. Histopathology. 2019;75(5):660–671. doi:10.1111/his.13955
   PubMed Web of Science ®Google Scholar
• Oto OA, Demir E, Mirioglu S, et al. Clinical significance of glomerular C3 deposition in primary membranous nephropathy. J Nephrol. 2021;34(2):581–587. doi:10.1007/s40620-020-00915-w
   PubMed Web of Science ®Google Scholar
• Tsai SF, Wu MJ, Chen CH. Low serum C3 level, high neutrophil-lymphocyte-ratio, and high platelet-lymphocyte-ratio all predicted poor long-term renal survivals in biopsy-confirmed idiopathic membranous nephropathy. Sci Rep. 2019;9(1):6209. doi:10.1038/s41598-019-42689-7
   PubMed Web of Science ®Google Scholar
• Chen Y, Tang L, Feng Z, et al. Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function. J Nephrol. 2014;27(3):307–316. doi:10.1007/s40620-014-0057-0
   PubMed Web of Science ®Google Scholar
• Li W, Zhao Y. Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis. Int Urol Nephrol. 2019;51(9):1581–1596. doi:10.1007/s11255-019-02147-9
   PubMed Web of Science ®Google Scholar
• Yun HR, Kim H, Park JT, et al. Obesity, metabolic abnormality, and progression of CKD. Am J Kidney Dis. 2018;72(3):400–410. doi:10.1053/j.ajkd.2018.02.362
   PubMed Web of Science ®Google Scholar
• Dai P, Xie W, Yu X, Sun J, Wang S, Kawuki J. Efficacy and cost of different treatment in patients with idiopathic membranous nephropathy: a network meta-analysis and cost-effectiveness analysis. Int Immunopharmacol. 2021;94:107376. doi:10.1016/j.intimp.2021.107376
   Web of Science ®Google Scholar
• Zhang BO, Cheng M, Yang M, et al. Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point. Biomed Rep. 2016;4(2):147–152. doi:10.3892/br.2015.555
   PubMed Web of Science ®Google Scholar
• Liu F, Chen S, Zhao W, et al. Urine uric acid excretion levels are positively associated with obesity and abdominal obesity in type 2 diabetes patients without chronic kidney disease. Diabetes Metab Syndr Obes. 2021;14:4691–4703. doi:10.2147/DMSO.S335558
   Web of Science ®Google Scholar
• Xu T, Sheng Z, Yao L. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment. Front Med. 2017;11(3):340–348. doi:10.1007/s11684-017-0570-3
   PubMed Web of Science ®Google Scholar
• Díaz-Méndez C, Adams J. The combined used of quantitative and qualitative longitudinal methods in the study of obesity. Gac Sanit. 2021;35(6):569–579. doi:10.1016/j.gaceta.2020.05.008
   Web of Science ®Google Scholar
• Zhao Y, Qie R, Han M, et al. Association of BMI with cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of cohort studies. NMCD. 2021;31(7):1976–1984. doi:10.1016/j.numecd.2021.03.003
   Web of Science ®Google Scholar
• Berthoux F, Mariat C, Maillard N. Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy. Nephrol Dial Transplant. 2013;28(Suppl 4):iv160–iv166. doi:10.1093/ndt/gft286
   PubMed Web of Science ®Google Scholar
• Panwar B, Hanks LJ, Tanner RM, et al. Obesity, metabolic health, and the risk of end-stage renal disease. Kidney Int. 2015;87(6):1216–1222. doi:10.1038/ki.2014.384
   PubMed Web of Science ®Google Scholar
• Park S, Lee S, Kim Y, et al. Reduced risk for chronic kidney disease after recovery from metabolic syndrome: a nationwide population-based study. Kidney Res Clin Pract. 2020;39(2):180–191. doi:10.23876/j.krcp.20.016
   Web of Science ®Google Scholar
• D’Agati VD, Chagnac A, de Vries AP, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453–471. doi:10.1038/nrneph.2016.75
   PubMed Web of Science ®Google Scholar
• Kim SJ, Koo HM, Lim BJ, et al. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One. 2012;7(7):e40495. doi:10.1371/journal.pone.0040495
   PubMed Web of Science ®Google Scholar
• Sarier M, Demir M, Goktas S, et al. Results of real-time multiplex polymerase Chain reaction assay in renal transplant recipients with sterile pyuria. Transplant Proc. 2017;49(6):1307–1311. doi:10.1016/j.transproceed.2017.02.051
   PubMed Web of Science ®Google Scholar